CoChat

The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review

Open access
Rhodes, Emily, Wilson, Maria, Robinson, Alysia, Hayden, Jill A., Asbridge, Mark · 2019 · BMC Health Services Research

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.

Abstract

Background: In order to address the opioid crisis in North America, many regions have adopted preventative strategies, such as prescription drug monitoring programs (PDMPs). PDMPs aim to increase patient safety by certifying that opioids are prescribed in appropriate quantities. We aimed to synthesize the literature on changes in opioid-related harms and consequences, an important measure of PDMP effectiveness. Methods: We completed a systematic review. We conducted a narrative synthesis of opioid-related harms and consequences from PDMP implementation. Outcomes were grouped into categories by theme: opioid dependence, opioid-related care outcomes, opioid-related adverse events, and opioid-related legal and crime outcomes. Results: We included a total of 22 studies (49 PDMPs) in our review. Two studies reported on illicit and problematic use but found no significant associations with PDMP status. Eight studies examined the association between PDMP status and opioid-related care outcomes, of which two found that treatment admissions for prescriptions opioids were lower in states with PDMP programs (p < 0.05). Of the thirteen studies that reported on opioid-related adverse events, two found significant (p < 0.001 and p < 0.05) but conflicting results with one finding a decrease in opioid-related overdose deaths after PDMP implementation and the other an increase. Lastly, two studies found no statistically significant association between PDMP status and opioid-related legal and crime outcomes (crime rates, identification of potential dealers, and diversion). Conclusion: Our study found limited evidence to support overall associations between PDMPs and reductions in opioid-related consequences. However, this should not detract from the value of PDMPs’ larger role of improving opioid prescribing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12913-019-4642-8

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 PRISMA flow chart depicting the study selection and inclusion process and results
Fig. 1 PRISMA flow chart depicting the study selection and inclusion process and resultsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Research works printed but not linked: 7

  1. Brandeis University. Technical assistance guide: history of Prescription drug monitoring programs [internet]. 2018. Available from: https://www.pdmpassist.org/pdf/PDMP_admin/TAG_History_PDMPs_final_20180314.pdf
  2. McLaughlin S Empirical Essays to inform marijuana legalization and Prescription opioid Abuse policy [internet]. 2016. Available from: http://search.proquest.com/docview/1923434357/
  3. Veritas Health Innovation. Covidence Systematic Review Software. 2017.
  4. PRISMA. PRISMA: Transparent Reporting of Systematic Reviews and Meta-Analyses [Internet]. 2015 [cited 2019 Jan 29]. Available from: http://prisma-statement.org/prismastatement/Checklist.aspx
  5. Microsoft. Excel. 2016.
  6. StataCorp. Stata 15. 2017.
  7. Asbridge M, Hayden J, Campbell S, Wilson M, Macdougall P. Utilization and effectiveness of Prescription monitoring programs : a systematic review (CIHR Report). Halifax: In Press; 2018.

Cited by

See all 117

Metadata

Authors
Rhodes, E., Wilson, M., Robinson, A., Hayden, J. A., & Asbridge, M.
Affiliations
Dalhousie University (CA)
Corresponding author
Asbridge, Mark
Venue
BMC Health Services Research
Published
2019-11-01
Volume
19
Issue
1
Pages
784-784
ISSN
1472-6963 (ISSN-L)
OpenAlex
W2988262664
Cited by
103
References
53
Citations by year
2026: 6 · 2025: 9 · 2024: 10 · 2023: 26 · 2022: 20 · 2021: 26 · 2020: 6
FWCI
2.13
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Health Services Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • uO Research (University of Ottawa) (submittedVersion, public-domain)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Canadian Institutes of Health Research (397982)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
prescription drug monitoring programs, opioid epidemic, opioid-related harms, opioid prescribing, opioid use disorder, opioid overdose deaths, opioid side effects, illicit opioid use, drug diversion
MeSH terms
Prescription Drug Monitoring Programs, Humans, Opioid-Related Disorders, Program Evaluation, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review. https://app.cochat.ai/papers/10.1186/s12913-019-4642-8
The paper
Rhodes, E., Wilson, M., Robinson, A., Hayden, J. A., & Asbridge, M. (2019). The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review. BMC Health Services Research. https://doi.org/10.1186/s12913-019-4642-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.